In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

Infect Drug Resist · 2018 · PMC6208934 · PMID 30464540

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Compared to the NS rates (1999–2003) of Taiwanese NTS isolates, in which Salmonella enterica serovar Choleraesuis accounted for most MDR-NTS isolates according to the study by Su et al, 26 an increasing trend in the ciprofloxacin NS rate (5.0% vs 21.3%) was found among the Taiwanese NTS isolates in 2017.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.